RFP | January 6, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases announces the availability of funding for implementation of the Small Business Innovation Research to Develop New Diagnostic, Monitoring, and Therapeutics Technologies for the Complications of Type 1 Diabetes (R43/R44) Grant. The purpose of this grant is to stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality . . .